Nuo Therapeutics, Inc. (AURX)
- Sector
- Healthcare
- Industry
- Biotechnology
- Last price
- $1.07
- As of
Kresmion compiles this page from AURX's SEC filings, its 13F institutional holders and the market events Kresmion detects, each linked to its source.
Nuo Therapeutics, Inc. (AURX): no institutional manager tracked by Kresmion reported a non-option position in the latest Form 13F reporting quarter, and the most recent SEC filing on record for the company is a Form 8-K filed 2026-10-06.
See the full AURX dossier
Price with insider and filing markers, who is positioning, fundamentals and peers for AURX on one page. Preview it with sample data, then open it live with a free account.
Preview the AURX dossierActive events for AURX
- lowEarnings below estimates
Q4-2010: EPS $-0.05 vs $-0.0408 estimate, -0.01 on a near-zero consensus
- lowEarnings below estimates
Q1-2011: EPS $-0.05 vs $-0.0408 estimate, -0.01 on a near-zero consensus
- lowEarnings above estimates
Q1-2011: EPS $-0.03 vs $-0.0408 estimate, +0.01 on a near-zero consensus
FREE, NO ACCOUNT
Every event on AURX, as it fires
New filings, 13F moves and cross asset events on AURX land in the record first.
No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.
No non-option holdings from tracked managers in this reporting quarter.
Recent SEC filings, AURX
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
Going concern statement
AURX's 10-Q filed Aug 14, 2026 states:
As such, we believe that substantial doubt about our ability to continue as a going concern exists.
Read the 10-Q on SEC EDGAR Every company with a going concern statement
More data on AURX
Related tickers
Cite this data
Kresmion counts the managers it follows that reported a non-option position in AURX on Form 13F-HR for the latest reporting quarter, orders those positions by the value each filing reports, and lists the company's latest SEC filings and the events Kresmion recorded on AURX in the last 180 days.
Upstream: SEC EDGAR filings for AURX
Kresmion, "Nuo Therapeutics, Inc. (AURX) institutional holdings and SEC filings", data as of 2026-10-06, https://kresmion.com/research/AURX. Upstream data: SEC EDGAR filings for AURX.
Link to this data (HTML):
<a href="https://kresmion.com/research/AURX">Nuo Therapeutics, Inc. (AURX) institutional holdings and SEC filings (Kresmion)</a>
Writing about this? Press contact and ready-to-quote figures
Follow AURX on a live board
Kresmion is a source-first market terminal for cross-asset market intelligence. Open a board scoped to AURX for its filings, 13F changes, insider trades, options positioning, and confluence read in one view, each with its source.